CompanyProfileNomu

Actions

Almujtama Alraida Medical Co.

9592
ALMUJTAMA MEDICAL
Add To Watchlist
In your Watchlist
Add To Watchlist
  • Nomu - Parallel Market
  • Consumer Staples Distribution & Retail

Stats Overview

  • Prev. Close 31.95
  • Open 32.00
  • High 32.10
  • Low 31.00
  • No. Of Trades 34
  • Avg. Trade size* 135
  • Volume Traded 4,583
  • Value Traded 144,428.70

Performance

ALMUJTAMA MEDICAL
0.15 ( 0.47% )
Compare
Name Price Change %
Almujtama Alraida Medical Co. 32.00 0.47%
Quote delayed by 5 mins
  • *Average Trade Size = Cumulative / # of Trades
  • **52 Week Price Change =   (Current Price - Price year ago) / Price year ago x 100
  • Historical prices & volume traded data are adjusted to account for all corporate actions.
  • MO: Market Order

Trade Updates

Trade Updates

Price
32.10
% Change
0.47
Volume Traded
100

Best Bid

Price 31.30
Volume 170

Best Offer

Price 32.10
Volume 3,224

52 WEEK

High
48.00
2023/11/22
Low
28.80
2023/12/24
change
0.0

PERFORMANCE

Start of Year
29.7
Year ago
3 Years ago

Compare Selected

Select A Maximum Of 5 Companies

Compare Selected

LoginPortletPopupv2

Actions

AddtoWatchlistv2

Actions

Add to watchlist

AnnouncmentandCorporateAction

Actions
Jump To :
  • Announcements & Corporate Actions
  • Dividends
  • Financials
  • Shareholding
  • Peer Comparison
  • Company Profile

Announcements

  • Almujtama Alraida Medical Co. Announces the appointment of a member to the vacant seat on the Board of Directors

    9592
    ALMUJTAMA MEDICAL 0.47 %
    1445/08/01     11/02/2024 08:07:29
  • Almujtama Alraida Medical Co. Announces the approval of the Board of Directors to contract with the Bright Screens Company (a related party) in the amount of 1,767,780 Saudi riyals

    9592
    ALMUJTAMA MEDICAL 0.47 %
    1445/07/13     25/01/2024 08:03:48
  • Almujtama Alraida Medical Co. Announces the appointment of a Vice Chairman of the Board of Directors

    9592
    ALMUJTAMA MEDICAL 0.47 %
    1445/06/18     31/12/2023 08:52:29
  • Almujtama Alraida Medical Co. Announces Appointment of a CEO

    9592
    ALMUJTAMA MEDICAL 0.47 %
    1445/06/18     31/12/2023 08:46:39
  • Almujtama Alraida Medical Co. Announces Obtaining a Interest free loan

    9592
    ALMUJTAMA MEDICAL 0.47 %
    1445/06/18     31/12/2023 08:08:52
View All

Corporate Actions

Upcoming Events

    Past Events

      Jump To :
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Dividends

      Announced Date Eligibility Date Distribution Date Distribution Way Dividend Amount
      No data available in table

      CompanyProfileNomuv2Financials

      Actions
      Jump To:
      • Announcements & Corporate Actions
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Financials

      • FINANCIAL INFORMATION
      • FINANCIAL STATEMENTS AND REPORTS
      • Annually
      • Semi-Annual
      Balance Sheet 2022-12-31
      Total Assets
      334,426
      - - -
      Total Liabilities
      215,831
      - - -
      Total Shareholders Equity (After Deducting the Minority Equity)
      118,595
      - - -
      Total Liabilities and Shareholders Equity
      334,426
      - - -
      Statement of Income 2022-12-31
      Total Revenue (Sales/Operating)
      367,075
      - - -
      Net Profit (Loss) before Zakat and Tax
      21,175
      - - -
      Zakat and Income Tax
      -2,098
      - - -
      Net Profit (Loss) after Zakat and Tax
      19,077
      - - -
      Total Comprehensive Income
      21,943
      - - -
      Profit (Loss) per Share
      2.01
      - - -
      Cash Flow 2022-12-31
      Net Cash From Operating Activities
      18,540
      - - -
      Net Cash From Investing Activities
      -19,580
      - - -
      Net Cash From Financing Activities
      878
      - - -
      Cash and Cash Equivalents, Beginning of the Period
      4,217
      - - -
      Cash and Cash Equivalents, End of the Period
      4,055
      - - -
      All Figures in Thousands
      All Currency In SAR
      Last Update Date 2023-11-21

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.

      Balance Sheet 2023-06-30
      Total Assets
      405,073
      - - -
      Total Liabilities
      275,437
      - - -
      Total Shareholders Equity (After Deducting the Minority Equity)
      129,636
      - - -
      Total Liabilities and Shareholders Equity
      405,073
      - - -
      Statement of Income 2023-06-30
      Total Revenue (Sales/Operating)
      204,133
      - - -
      Net Profit (Loss) before Zakat and Tax
      12,730
      - - -
      Zakat and Income Tax
      -1,398
      - - -
      Net Profit (Loss) after Zakat and Tax
      11,332
      - - -
      Total Comprehensive Income
      11,041
      - - -
      Profit (Loss) per Share
      1.19
      - - -
      Cash Flow 2023-06-30
      Net Cash From Operating Activities
      45,190
      - - -
      Net Cash From Investing Activities
      -24,807
      - - -
      Net Cash From Financing Activities
      -17,040
      - - -
      Cash and Cash Equivalents, Beginning of the Period
      4,059
      - - -
      Cash and Cash Equivalents, End of the Period
      7,397
      - - -
      All Figures in Thousands
      All Currency In SAR
      Last Update Date 2023-11-21

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.

      Display Previous Periods
      Jump To :
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Shareholding Information

      • Board Of Directors
      • Foreign Ownership
      • Substantial Shareholders
      Time Period
      -
      Search
      Trading Date Shareholders Designation Shares Held Trading Day Shares Held Prev Trading Day Change
      2024-02-28 عمر يوسف يولداش خوجه Chairman 38.2924632% 38.2924632% 0
      2024-02-28 عبدالعزيز عمر يوسف خوجه Senior Executives 2.1652316% 2.1652316% 0
      2024-02-28 عبدالعزيز عمر يوسف خوجه Board of Directors 2.1652316% 2.1652316% 0
      2024-02-28 يوسف عمر خوجه يوسف Board of Directors 3.6301158% 3.6301158% 0
      • The listed company (Publisher) shall be responsible for the accuracy of the published information pertaining to the ownership of the Board of Directors, Chief Executive Officer or highest executive position, and the Chief Financial Officer. The listed company shall also be responsible for updating these information thereof. Therefore, the Saudi Stock Exchange (Tadawul) shall not be liable for the information contained therein, nor for any consequences that may result from the said information.
      for
      subs
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Peer Comparison

      • Table
      • Graphical
      Add Company

      Compare Selected

      Select a Maximum of 5 Companies

      Company Apply
      Almujtama Alraida Medical Co.
      Price 32.10
      Market Cap (SAR MN) 305
      P/E Ratio 13.46
      Index Name Index Level 1D Return
      Almujtama Alraida Medical Co. %
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Company Profile

      Company overview

      Al-Mujtama Al-Raida Medical Company''s core operations include operating pharmacies and retail in pharmaceutical products such as medicines and cosmetic products and medical equipment and medical supplies. In addition to providing pharmaceutical services in the Kingdom of Saudi Arabia

      Company History

      The company was initially established in 2001 as a sole proprietorship under the name of Almujtama Alhadithah Pharmacy by its founder Abdulaziz Omar Khojah under the commercial registration No. (4030134617) issued from the city of Jeddah on 11/05/1422 AH (corresponding to 01/08/2001 AD), then a series of individual institutions and companies were acquired later during different periods of time and were all combined under one umbrella in the name of Almujtama Al-Raida Medical Company registered under the commercial register No. (4030241534) issued from the city of Jeddah on 14/04/1434 AH (corresponding to 24/02/2013 AD).

      Company Bylaws

      Click here

      Equity Profile

      • Authorized Capital (SAR) 95,000,000
      • Issued Shares 9,500,000
      • Paid Up Capital (SAR) 95,000,000
      • Par Value/Share 10
      • Paid Up Value/Share 10

      Last Update :2023-11-21

      Investment limits

      There are no investment limits on the company's shares as per the amended Rules for Qualified Foreign Financial Institutions Investment in Listed Securities and Instructions for the Foreign Strategic Investors Ownership in Listed Companies based on Company's bylaw

       

      • Company Details
      • BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
      • Date Established

        2001/08/01

      • Financial Year End

        31/12

      • Listing Date

        2023/11/22

      • External Auditors

        [Talal Abu-Ghazaleh & Co]

      • ISIN CODE

        SA15U0K4LS18

      • Number of Employees

        775

      • Chairman

        Omar Yousuf Yoldash Khojah
        Non - Executive

        Omar Yousuf Yoldash Khojah
        • Bd Session Start
          2022-08-01
          Designation
          Chairman
        • Bd Session End
          2026-07-31
          Classification
          Non - Executive
      • Board of Directors

        Abdulaziz Omar Yousuf Khojah (Managing Director) Executive

        Abdulaziz Omar Yousuf Khojah (Managing Director)
        • Bd Session Start
          2022-08-01
          Designation
          Board of Directors
        • Bd Session End
          2026-07-31
          Classification
          Executive

        Yousuf Omar Yousuf Khojah Deputy Chairman - Executive

        Yousuf Omar Yousuf Khojah
        • Bd Session Start
          2022-08-01
          Designation
          Board of Directors
        • Bd Session End
          2026-07-31
          Classification
          Deputy Chairman - Executive

        Ahmad Abdulelah Mohammad Ali Maghrabi Independent

        Ahmad Abdulelah Mohammad Ali Maghrabi
        • Bd Session Start
          2022-08-01
          Designation
          Board of Directors
        • Bd Session End
          2026-07-31
          Classification
          Independent

        Abdulaziz Ahmed Abdullatif Bin Dayel Independent

        Abdulaziz Ahmed Abdullatif Bin Dayel
        • Bd Session Start
          2024-02-08
          Designation
          Board of Directors
        • Bd Session End
          2026-07-31
          Classification
          Independent
      • Senior Executives

        Abdulaziz Omar Yousuf Khojah CEO

        Abdulaziz Omar Yousuf Khojah
        • Bd Session Start
          2022-08-01
          Designation
          Senior Executives
        • Bd Session End
          -
          Classification
          CEO

        Rami Mamdouh Mohammad CFO

      Rami Mamdouh Mohammad
      • Bd Session Start
        2022-01-03
        Designation
        Senior Executives
      • Bd Session End
        -
        Classification
        CFO

      Investor Relations

      Contact Name:

      Investor Relations Department

      Company Address:

      Main Street, Al-Hamadania District, Jeddah

      Contact Details:

      Telephone: 920008144
      Fax: -
      Email: Investor-relations@almujtama.com.sa

      Company Website:

      www.almujtama.com.sa


      Add To Watchlist
      In your Watchlist
      Add To Watchlist

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.